Varicella in infants after implementation of the US varicella vaccination program

Pediatrics

Volumn 128, Issue 6, 2011, Pages 1071-1077

  Chaves, Sandra S ^a   Lopez, Adriana S ^a   Watson, Tureka L ^a   Civen, Rachel ^b   Watson, Barbara ^c,d   Mascola, Laurene ^b   Seward, Jane F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Acute Communicable Disease Control Program   (United States)

^c Division of Disease Control   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Active surveillance; Chickenpox; Infant varicella; Neonatal varicella; Varicella

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CHICKENPOX VACCINE;

AGE; ARTICLE; ASEPTIC MENINGITIS; ASTHMA; BACTERIAL INFECTION; CHICKENPOX; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; FEVER; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OTITIS MEDIA; PHARYNGITIS; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCAR FORMATION; SKIN INFECTION; UNITED STATES;

EID: 83155182581     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0017     Document Type: Article

References (32)

1. Preblud SR, Bregman DJ, Vernon LL. Deaths from varicella in infants. Pediatr Infect Dis. 1985;4(5):503-507 (Pubitemid 15019916)
2. Guess HA, Broughton DD, Melton LJ 3rd, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986;78(4 pt 2):723-727 (Pubitemid 16007074)
3. Preblud SR. Age-specific risks of varicella complications. Pediatrics. 1981;68(1):14-17 (Pubitemid 11061357)
4. Preblud SR, Orenstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis. 1984;3(6):505-509 (Pubitemid 15220591)
5. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis. 2000;182(2):383-390 (Pubitemid 30654820)
6. Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J Paediatr Child Health. 2000;36(2):108-113 (Pubitemid 30190591)
7. Baba K, Yabuuchi H, Takahashi M, Ogra PL. Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood. J Pediatr. 1982;100(6):881-885 (Pubitemid 12123582)
8. Pinquier D, Gagneur A, Balu L, et al. Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age. Clin Vaccine Immunol. 2009;16(4):484-487
9. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to varicellazoster virus in parturient women and their offspring during the first year of life. Pediatrics. 1976;58(5):692-696
10. Heininger U, Desgrandchamps D, Schaad UB. Seroprevalence of varicella-zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine. 2006;24(16):3258-3260
11. Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P. Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine. 2011;29(11):2222-2226
12. Pinquier D, Lécuyer A, Levy C, et al. Inverse correlation between varicella severity and level of anti-Varicella Zoster Virus maternal antibodies in infants below one year of age. Hum Vaccin. 2011;7(5):534-538
13. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-611 (Pubitemid 34252012)
14. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008;197(Suppl 2):S71-S75 (Pubitemid 351590150)
15. Nguyen H, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352(5):450-458 (Pubitemid 40175971)
16. Zhou F, Harpaz R, Jumaan AO, Winston CA,Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797-802 (Pubitemid 41175722)
17. Vollset SE. Confidence intervals for a binomial proportion [published correction appears in Stat Med. 1995;14(8):875]. Stat Med. 1993;12(9):809-824 (Pubitemid 23162483)
18. Lécuyer A, Levy C, Gaudelus J, et al. Hospitalization of newborns and young infants for chickenpox in France. Eur J Pediatr. 2010;169(10):1293- 1297
19. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J. 1992;11(6):441-445
20. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002; 21(10):931-935
21. Kavaliotis J. Acyclovir therapy in neonates. J Pediatr. 1992;119(4):655
22. Williams H, Latif A, Morgan J, Ansari BM. Acyclovir in treatment of neonatal varicella. J Infect. 1987;15(1):65-67
23. Huang YC, Lin TY, Lin YJ, Lien RI, Chou YH. Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr. 2001;160(2):91-94
24. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40
25. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010;340:c1626
26. Papania M, Baughman AL, Lee S, et al. Increased susceptibility to measles in infants in the United States. Pediatrics. 1999;104(5). Available at: www.pediatrics.org/cgi/content/full/104/5/e59
27. Szenborn L, Tischer A, Pejcz J, Rudkowski Z, Wójcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit. 2003;9(12):CR541-CR546 (Pubitemid 38016200)
28. Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2):132-137 (Pubitemid 38222785)
29. Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312-315
30. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284
31. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30
32. Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM. Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004. Public Health Rep. 2010;125(6):860-869